https://www.selleckchem.com/products/cx-5461.html
Proctitis is the least extensive type of ulcerative colitis, for which rectal therapy is rarely studied and is underused. This study evaluated the efficacy, safety, and patient's preference of a novel formulation of budesonide suppository 4 mg, compared with a commercially available budesonide rectal foam 2 mg, for the treatment of mild to moderate ulcerative proctitis. This was a randomised, double-blind, double-dummy, active-controlled trial. Patients were randomly assigned in a 11 ratio to receive either budesonide 4 mg suppository o
Like
Comment
Share
